MLMicaela Lurie

Micaela Lurie

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Micaela Lurie has a total of 41 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Distinct Cervicovaginal Cytokine Signatures Associated with Reproductive Tract Infections and Vaginal Dysbiosis Across Diverse Settings

    by Micaela Lurie, Tania Crucitti, Musalula Sinkala, Ramla F. Tanko, Aina Harimanana, Katherine Gill, Linda-Gail Bekker, Janneke Hhm van de Wijgert, Bich-Tram Huynh, Camille Fortas, et al.

    Background: Reproductive tract infections (RTIs) and bacterial vaginosis (BV) are major causes of genital inflammation and reproductive morbidity, yet often remain undetected under syndromic management. We evaluated cervicovaginal cytokine signatures associated with RTIs and vaginal dysbiosis in women from South Africa, Madagascar, and Zimbabwe. Methods: Vaginal swabs from 676 non-pregnant, sexually-active women (18–35 years) were tested for Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG) , Trichomonas vaginalis (TV) , Mycoplasma genitalium (MG) , Candida spp., and BV by PCR and Nugent scoring. Cervicovaginal IL-1α, IL-1β, and IP-10 concentrations were measured by ELISA, and associations with RTIs and vaginal dysbiosis were assessed using multivariable regression and population attribution fraction analyses. Results: BV (Nugent 7–10) was the most prevalent (50.4%) and dominant contributor to elevated IL-1α and IL-1β, accounting for >60% of women with high cytokine levels. Intermediate vaginal microbiota (Nugent 4–6) showed similar inflammatory profiles and, with BV, was associated with reduced IP-10. NG was independently associated with elevated IL-1α and IL-1β, CT with elevated IL-1β and IP-10, TV with elevated IP-10, Candida spp. with elevations in all cytokines, while MG showed no independent associations. Most RTIs and vaginal dysbiosis were asymptomatic, with similar inflammatory profiles regardless of symptoms. Despite variation in baseline cytokine concentrations, infection-associated inflammatory signatures were consistent across countries. Conclusions: RTIs and vaginal dysbiosis elicited consistent inflammatory signatures across countries, with BV and intermediate microbiota driving much of the inflammatory burden. Their frequent occurrence in asymptomatic women highlights the potential of host-response biomarkers to identify otherwise undetected genital inflammation. Lay summary: Reproductive tract infections and bacterial vaginosis (BV; a common condition in which the normal protective bacteria in the vagina are replaced by a mix of other bacteria) are major causes of poor reproductive health, but many women have no symptoms and remain undiagnosed. In this study, we measured inflammatory proteins in vaginal samples from 676 women in South Africa, Madagascar, and Zimbabwe and examined how these markers were associated with infections and changes in the vaginal microbiota. We found that BV was the strongest driver of genital inflammation and that women with intermediate vaginal microbiota, often considered a transitional microbial state, showed similar inflammatory profiles. Different infections were associated with distinct inflammatory patterns, but many women with substantial inflammation had no symptoms. Importantly, these inflammatory responses were broadly similar across all three countries. Together, these findings highlight important limitations of symptom-based diagnosis and support the development of host-response diagnostics that can identify by reproductive tract infections and vaginal dysbiosis, including in women who would otherwise remain undiagnosed.

  • Open Access

    Chlamydia trachomatis -specific T Cell Immunity Reflects Widespread Exposure in South African Adolescents and Young Women

    by Rubina Bunjun, Micaela Lurie, Smritee Dabee, Shaun Barnabas, Venessa Maseko, Shameem Z Jaumdally, Hoyam Gamieldien, David A Lewis, Heather B Jaspan, Katherine Gill, et al.

    Background: Chlamydia trachomatis remains the most prevalent bacterial sexually transmitted infection worldwide, disproportionately affecting adolescent girls and young women (AGYW). Vaccine development is hindered by a limited understanding of protective immunity, particularly in the context of multiple exposures and immunopathology. Methods: We characterized mucosal inflammation and systemic immune responses to C. trachomatis in South African AGYW (n = 145), stratified by exposure history based on nucleic acid amplification testing (NAAT) and serology (Ab). Specifically, cervicovaginal cytokines, cervical T cell activation, and C. trachomatis-specific CD4+ T cell responses were assessed. Results: A NAAT+/Ab + status, signifying untreated/recurrent infection, was associated with increased cervical T cell activation. These women all had detectable C. trachomatis-specific CD4+ T cells in blood; however, the magnitude of the response was 2.4-fold lower than in NAAT−/Ab + (cleared infection) or NAAT+/Ab− (primary infection) groups. C. trachomatis-specific multifunctional CD4+ T cells were highest in NAAT−/Ab + women, and nearly absent in those who were NAAT+/Ab +. Notably, systemic C. trachomatis-specific Th1 responses were overall inversely correlated with genital tract concentrations of inflammatory cytokines, including IL-1β, TNF, and IL-17A. Conclusions: Both the magnitude and quality of the systemic CD4+ T cell responses are critical components of protective immunity to C. trachomatis and may limit mucosal immunopathology, informing vaccine strategies in high-risk populations.